Dysfunctional syndromes and fibromyalgia: A 2012 critical digest

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL.74, 2012, Pages

  Sarzi Puttini, Piercarlo ^a   Atzeni, Fabiola ^a,b,c,d,e   Di Franco, Manuela ^b   Buskila, Dan ^c   Alciati, Alessandra ^d   Giacomelli, Camillo ^e   Rossi, Alessandra ^e   Bazzichi, Laura ^e  

^a UNIVERSITY OF MILAN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d Department of Clinical Neurosciences ^*  (Italy)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

Dysfunctional syndromes; Fibromyalgia

Indexed keywords

ALPHA 1 ANTITRYPSIN; AMINE OXIDASE (FLAVIN CONTAINING); AUTOANTIBODY; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; CATECHOL METHYLTRANSFERASE; DOPAMINE TRANSPORTER; GAMMA INTERFERON; HEAT SHOCK PROTEIN 72; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NORADRENALIN; PEROXIDE; PLACEBO; PROBIOTIC AGENT; RITUXIMAB; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SODIUM CHANNEL NAV1.7; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE; UNINDEXED DRUG; VIRUS ANTIBODY;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ANTINOCICEPTION; ANXIETY DISORDER; AUTOIMMUNE THYROIDITIS; AYURVEDA; BIPOLAR DISORDER; BODY MASS; CENTRAL SENSITIZATION; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSPEPSIA; EPSTEIN BARR VIRUS INFECTION; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FAMILIAL MEDITERRANEAN FEVER; FIBROMYALGIA; FUNCTIONAL SOMATIC DISORDER; GASTROINTESTINAL TRANSIT; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; HYPNOSIS; IMMUNE DYSREGULATION; IMMUNOREGULATION; INFLAMMATION; IRRITABLE COLON; KINESIOTHERAPY; MOTOR PERFORMANCE; NOCICEPTION; OXIDATIVE STRESS; PAIN; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; Q FEVER; QUALITY OF LIFE; REVIEW; ROSS RIVER ALPHA VIRUS; SEXUAL DYSFUNCTION; SOMATIZATION; SPA TREATMENT; SPINAL GANGLION; SYMPTOMATOLOGY; XENOTROPIC MULV RELATED VIRUS; AFFECT; CHRONIC PAIN; COGNITION; DAILY LIFE ACTIVITY; PROGNOSIS; PSYCHOLOGICAL ASPECT; SYNDROME;

ACTIVITIES OF DAILY LIVING; AFFECT; CHRONIC PAIN; COGNITION; COMORBIDITY; FATIGUE SYNDROME, CHRONIC; FIBROMYALGIA; HUMANS; IRRITABLE BOWEL SYNDROME; PROGNOSIS; QUALITY OF LIFE; SYNDROME;

EID: 84874961979     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. NIJS J, MEEUS M, VAN OOSTERWIJCK J et al, Treatment of central sensitization in patients with 'unexplained' chronic pain, what options do we have? Expert Opin Pharmacother 2011; 12, 1087-98
2. BAZZICHI L, SERNISSI F, CONSENSI A, GIACOMELLI C, SARZI-PUTTINI P, Fibromyalgia, a critical digest of the recent literature. Clin Exp Rheumatol 2011; 29 (Suppl. 69), S1-11.
3. SARZI-PUTTINI P, ATZENI F, MEASE PJ, Chronic widespread pain, from peripheral to central evolution. Best Pract Res Clin Rheumatol 2011; 25, 133-9.
4. PHILLIPS K, CLAUW DJ, Central pain mechanisms in rheumatic diseases, Future directions. Arthritis Rheum 2012 Oct 8 [Epub ahead of print].
5. KINDLER LL, BENNETT RM, JONES KD, Central sensitivity syndromes, mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders. Pain Manag Nurs 2011; 12, 15-24.
6. LUCINI D, PAGANI M, From stress to functional syndromes, an internist's point of view. Eur J Intern Med 2012; 23, 295-30.
7. SARZI-PUTTINI P, ATZENI F, SALAFFI F, CAZZOLA M, BENUCCI M, MEASE PJ, Multidisciplinary approach to fibromyalgia, what is the teaching? Best Pract Res Clin Rheumatol 2011; 25, 311-9
8. SOMMER C, HÄUSER W, BURGMER M et al., Etiology and pathophysiology of fibromyalgia syndrome. Schmerz 2012; 26, 259-67.
9. TOMŠ J, Updated view of fibromyalgia. Cas Lek Cesk 2012; 151, 415-9.
10. NEYAL M, YIMENICIOGLU F, AYDENIZ A et al., Plasma nitrite levels, total antioxidant status, total oxidant status, and oxidative stress index in patients with tension-type headache and fibromyalgia. Clin Neurol Neurosurg 2012 Oct 11 [Epub ahead of print].
11. CORDERO MD, COTÁN D, DEL-POZO-MARTÍN Y et al, Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Nutrition 2012; 28; 1200-3.
12. CORDERO MD, DÍAZ-PARRADO E, CARRIÓN AM et al., Is Inflammation a Mitochondrial Dysfunction-Dependent Event in Fibromyalgia? Antioxid Redox Signal 2012 Nov 16 [Epub ahead of print].
13. KIM SE, CHANG L, Overlap between functional GI disorders and other functional syndromes, what are the underlying mechanisms? Neurogastroenterol Motil 2012; 24, 895-913
14. TAGOE CE, ZEZON A, KHATTRI S, Rheumatic manifestations of autoimmune thyroid disease, the other autoimmune disease. J Rheumatol 2012; 39, 1125-9.
15. SUK JH, LEE JH, KIM JM, Association between thyroid autoimmunity and fibromyalgia. Exp Clin Endocrinol Diabetes 2012; 120, 401-4.
16. XIAO Y, HAYNES WL, MICHALEK JE, RUSSELL IJ, Elevated serum high-sensitivityC-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol Int 2012 Nov 4 [Epub ahead of print].
17. BOTE ME, GARCÍA JJ, HINCHADO MD, ORTEGA E, Inflammatory/Stress feedback dysregulation in women with fibromyalgia. Neuroimmunomodulation. 2012; 19, 343-51.
18. KADETOFF D, LAMPA J, WESTMAN M, ANDERSSON M, KOSEK E., Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol 2012; 242, 33-8.
19. ORTEGA E, BOTE ME, GIRALDO E, GARCÍA JJ, Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients. Scand J Med Sci Sports 2012; 22, 104-12.
20. LOW LA, SCHWEINHARDT P, Early life adversity as a risk factor for fibromyalgia in later life. Pain Res Treat 2012; 2012, 140832.
21. MARTÍNEZ-JAUAND M, SITGES C, RODRÍGUEZ V et al., Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain 2012 Apr 24 [Epub ahead of print].
22. DESMEULES J, PIGUET V, BESSON M et al., Psychological distress in fibromyalgia patients, a role for catechol-O-methyl-transferase Val158met polymorphism. Health Psychol 2012; 31, 242-9.
23. LIGHT KC, WHITE AT, TADLER S, IACOB E, LIGHT AR, Genetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome. Pain Res Treat 2012; 2012, 427869.
24. SCHMECHEL DE, EDWARDS CL, Fibromyalgia, mood disorders, and intense creative energy, A1AT polymorphisms are not always silent. Neurotoxicology 2012 Mar 10 [Epub ahead of print].
25. SKOUEN JS, SMITH AJ, WARRINGTON NM et al., Genetic variation in the beta-2 adrenergic receptor is associated with chronic musculoskeletal complaints in adolescents. Eur J Pain 2012; 16, 1232-42.
26. KARAKUS N, YIGIT S, INANIR A, INANIR S, TOPRAK H, OKAN S, Association between sequence variations of the Mediterranean fever gene and fibromyalgia syndrome in a cohort of Turkish patients. Clin Chim Acta 2012; 414C, 36-40.
27. VARGAS-ALARCON G, ALVAREZ-LEON E, FRAGOSO JM et al., A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. BMC Musculoskelet Disord 2012; 13, 23.
28. MERGENER M, BECKER RM, DOS SANTOS AF, DOS SANTOS GA, DE ANDRADE FM, Influence of the interaction between environmental quality and T102C SNP in the HTR2A gene on fibromyalgia susceptibility. Rev Bras Reumatol 2011; 51, 594-602.
29. LEE YH, CHOI SJ, JI JD, SONG GG, Candidate gene studies of fibromyalgia, a systematic review and meta-analysis. Rheumatol Int 2012; 32, 417-26.
30. BATMAZ I, SARIYILDIZ MA, DILEK B et al., Sexuality of men with fibromyalgia, what are the factors that cause sexual dysfunction? RheumatolInt 2012 Nov 4 [Epub ahead of print].
31. RICO-VILLADEMOROS F, CALANDRE EP, RODRÍGUEZ-LÓPEZ CM et al., Sexual functioning in women and men with fibromyalgia. J Sex Med 2012; 9, 542-9.
32. BAZZICHI L, GIACOMELLI C, ROSSI A et al., Fibromyalgia and sexual problems. Reumatismo 2012; 64, 261-7.
33. YILMAZ H, YILMAZ SD, POLAT HA, SALLI A, ERKIN G, UGURLU H, The effects of fibromyalgia syndrome on female sexuality, a controlled study. J Sex Med 2012; 9, 779-85.
34. ABLIN JN, GUREVITZ I, COHEN H, BUSKILA D, Sexual dysfunction is correlated with tenderness in female fibromyalgia patients. Clin Exp Rheumatol 2011; 29 (Suppl. 69), S44-8.
35. OZKURT S, DÖNMEZ A, ZEKI KARAGÜLLE M, UZUNOǦLU E, TURAN M, ERDOǦAN N, Balneotherapy in fibromyalgia, a single blind randomized controlled clinical study. Rheumatol Int 2012; 32, 1949-54.
36. GUIDELLI GM, TENTI S, DE NOBILI E, FIORAVANTI A, Fibromyalgia syndrome and spa therapy, myth or reality? Clin Med Insights Arthritis Musculoskelet Disord 2012; 5, 19-26
37. MADDALI BONGI S, DEL ROSSO A, DI FELICE C, CALÀ M, GIAMBALVO DAL BEN G, Rességuier method and Qi Gong sequentially integrated in patients with fibromyalgia syndrome. Clin Exp Rheumatol 2012; 29 (Suppl. 74), S51-S58.
38. LIU W, ZAHNER L, CORNELL M et al., Benefit of qigong exercise in patients with fibromyalgia, a pilot study. Int J Neurosci 2012; 122, 657-64.
39. LYNCH M, SAWYNOK J, HIEW C, MARCON D, A randomized controlled trial of qigong for fibromyalgia. Arthritis Res Ther 2012; 14, R178.
40. CHAN CL, WANG CW, HO RT et al., A systematic review of the effectiveness of qigong exercise in supportive cancer care. Support Care Cancer 2012; 20, 1121-33.
41. CHAN CL, WANG CW, HO RT, NG SM, ZIEA ET, WONG VT, Qigong exercise for the treatment of fibromyalgia, a systematic review of randomized controlled trials. J Altern Complement Med 2012; 18, 641-6.
42. CASTEL A, CASCÓN R, PADROL A, SALA J, RULL M, Multicomponent cognitive-behavioral group therapy with hypnosis for the treatment of fibromyalgia, long-term outcomeJ Pain 2012; 13, 255-65
43. RASMUSSEN LB, MIKKELSEN K, HAUGEN M, PRIPP AH, FIELDS JZ, FØRRE ØT, Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway II - a 24-month follow-up pilot study. Clin Rheumatol 2012; 31, 821-7.
44. PENG PW, Tai chi and chronic pain. Reg Anesth Pain Med 2012; 37, 372-82.
45. WANG C, Role of tai chi in the treatment of rheumatologic diseases. Curr Rheumatol Rep 2012; 14, 598-603.
46. KOZASA EH, TANAKA LH, MONSON C, LITTLE S, LEAO FC, PERES MP, The effects of meditation-based interventions on the treatment of fibromyalgia. Curr Pain Headache Rep 2012; 16, 383-7.
47. CHRISTLEY Y, DUFFY T, MARTIN CR, Areview of the definitional criteria for chronic fatigue syndrome. J Eval Clin Pract 2012; 18, 25-31.
48. FUKUDA K, STRAUS S, HICKIE I, SHARPE M, DOBBINS J, KOMAROFF A, THE INTERNATIONAL CHRONIC FATIGUE SYNDROME STUDY GROUP, The chronic fatigue syndrome, a comprehensive approach to its definition and study. Ann Intern Med 1994; 121, 953-9.
49. CARRUTHERS BM, VAN DE SANDE MI, DE MEIRLEIR KL et al., Myalgic encephalomyelitis, International Consensus Criteria. J Intern Med 2011; 270, 327-38.
50. NIJS J, MEEUS M, VAN OOSTERWIJCK J et al., In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Invest 2012; 42, 203-12.
51. NACUL LC, LACERDA ME, PLEBY D et al., Prevalence of myalgic encephalomyelitis/ Chronic fatigue syndrome (ME/CFS) in three regions of England, a repeated crosssectional study in primary care. BMC Medicine 2011; 9, 91.
52. VINCENT A, BRIMMER DJ, WHIPPLE MO et al., Prevalence, Incidence, and Classification of chronic fatigue syndrome in Olmsted County, Minnesota, as estimated using the Rochester Epidemiology Project. Mayo Clin Proc 2012 Nov 7 [Epub ahead of print].
53. ANDERSON VR, JASON LA, HLAVATY LE, PORTER N, CUDIA J, A review and meta-synthesis of qualitative studies on myalgic encephalomyelitis/ chronic fatigue syndrome. Patient Educ Couns 2012; 86, 147-55.
54. MEEUS M, VAN EUPEN I, VAN BAARLE E et al., Symptom fluctuations and daily physical activity in patients with chronic fatigue syndromes, A case-control study. Arch Phys Med Rehabil 2011; 92, 1820-6.
55. RAVINDRAN MK, ZHENG Y, TIMBOL C, MERCK SJ, BARANIUK JN, Migraine headaches in chronic fatigue syndrome (CFS), comparison of two prospective cross-sectional studies. BMC Neurology 2011; 11, 30.
56. CLARK C, GOODWIN L, STANSFELD SA, HOTOPF M, WHITE PD, Premorbid risk markers for chronic fatigue syndrome in the 1958 British birth cohort. British J Psychiatry 2011; 199, 323-9.
57. NATER UM, MALONY E, HEIM C, REEVES WC, Cumulative life stress in chronic fatigue syndrome. Psychiatry Research 2011; 189, 318-20.
58. TAYLOR RR, O'BRIEN J, KIELHOFNER G, LEE SW. KATZ B, CYNTHIA M, The occupational and quality of life consequences of chronic fatigue syndrome/myalgic encephalomyelitis in young people. Br JJ Occup Ther 2010; 73, 524-30.
59. SANTAMARIA-PEREZ P, EIROA-OROSA FJ FRENICHE V et al., length of illness dose not predict cognitive dysfunction in chronic fatigue syndrome. Appl Neuropsychol 2011; 18, 216-622.
60. PIRAINO B, VOLLMER-CONNA U, LLOYD AR, Genetic associations of fatigue and other symptom domains of the acute sickness response to infection. Brain Behav Immun 2012; 26, 552-8.
61. BOWER JE, Fatigue, brain, behavior, and immunity, Summary of the 2012 Name Serieson fatigue. Brain Behav Immun 2012; 26, 1220-3.
62. CHO HJ, BOWER JE, KIEFE CI, SEEMAN TE, IRWIN MR, Early life stress and inflammatory mechanisms of fatigue in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Brain Behav Immun 2012; 26, 859-65.
63. LATTIE EG, ANTONI MH, FLETCHER MA et al., Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome. Brain Behav Immun 2012; 26, 849-58.
64. MASE M, KUBERA M, UYTTERHOEVEN M, VRYDAGS N, BOSMANS E, Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med Sci Monti 2011; 17, SC 11-15
65. TAK LM, CLEARE AJ, ORMEL J et al., Metaanalysis and meta-regression of hypothalamic pituitary adrenal axis activity in functional somatic disorders. Biological Psychology 2011; 87, 183-94.
66. KISHI A, NATELSON BH, TOGO F, STUZIK ZR, RAPOPORT DM, YAMAMOTO Y, Sleep stage transitions in chronic fatigue syndrome patients with or without fibromyalgia. Conf Proc IEEE Eng Med Biol Soc 2010; 5391-4.
67. ELFAITOURI A, SHAO X, UEFSTEDT JM et al., Murine gammaretrovirus group G3 was not found in Swedish patients with myalgic encephalomyelitis, chronic fatigue syndrome and fibromyalgia. PLos One 2011; 6, e24602.
68. STEFFEN I, TYRRELL DL, STEIN E et al., No evidence for XMRV nucleic acids infectious virus or anti - XMRV anti bodies in Canadian patients with chronic fatigue syndrome. Plos One 2011; 6, e27870.
69. HOHN O, BANNERT N, Origin of XMRV and its demise as a human pathogen associated with chronic fatigue syndrome. Viruses 2011; 3, 1312-9.
70. TOMIC S, BRKIC S, MARIC D, MIKIC AN, Lipid and protein oxidation in female patients with chronic fatigue syndrome. Arch Med Sci 2012; 8, 886-91.
71. BEAUMONT A, BURTON AR, LEMON J, BENNETT BK, LLOYD A, VOLLMER-CONNA U, Reduced cardiac vagal modulation impacts on cognitive performance in chronic fatigue syndrome. PLoS One 2012; 7, e49518.
72. VAN CAUWENBERGH D, DE KOONING M, ICKMANS K, NIJS J, How to exercise people with chronic fatigue syndrome, evidencebased practice guidelines. Eur J Clin Invest 2012; 42, 1136-44.
73. RIMES KA, WINGROVE J, Mindfulness-based cognitive therapy for people with chronic fatigue syndrome still experiencing excessive fatigue after cognitive behavior therapy, A pilot randomized study. Clin Psychol Psychother 2011 Oct 9 [Epub ahead of print].
74. SCHREURS KMG, VEEHOF MM, PASSADE L, VOLLENBROEK - HUTTEN MMR, Cognitive behavioral treatment for chronic fatigue syndrome in a rehabilitation setting, effectiveness and predictors of outcome. BehaviorResearch Ther 2011; 49, 908-13.
75. ALRAEK T, LEE MS, CHOI TY, CAO H, LIU J, Complementary and alternative medicine for patients with chronic fatigue syndrome, a systematic review. BMC Complement Altern Med 2011; 11, 87.
76. SPITZER AR, BROADMAN M, Treatment of the narcoleptiform sleep disorder in chronic fatigue syndrome and fibromyalgia with sodium oxybate. Pain Pract 2010; 10, 54-9.
77. FLUGE O, BRULAND O, RISA K et al., Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo controlled study. Plos One 2011; 6, e26358.
78. WHITE DL. SAVAS LS, DACI K et al., Trauma history and risk of irritable bowel syndrome in women veterans. Aliment Pharmacol Ther 2010; 32, 551-61.
79. SUZUKI H, HIBI T, Overlap syndrome of functional dyspepsia and irritable bowel syndrome are both diseases mutually exclusive? J Neurogastroenterol Motil 2011; 17, 360-5
80. BASU PP, SHAH NJ, KRISHNASWAMY N, PACANA T, Prevalence of restless legs syndrome in patients with irritable bowel syndrome. World J Gastroentrol 2011; 17, 4404-7.
81. LARSSON MB, TILLISCH K, CRAIG AD et al., Brain responses to expectation and delivery of a visceral stimulus in IBS reflect visceral sensitivity thresholds. Gastroentrology 2012; 142, 463-472.
82. KRUIS W, CHRUBASIK S, BOEHM S, STANGE C, SCHULZE J, A double blind placebo controlled trial to study therapeutic effects at probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. In J Colorectal Dis 2012; 27, 467-74
83. FORD AC, TALLEY NJ, Irritable bowel syndrome. BMJ 2012; 345, e5836.
84. RUEPERT L, QUARTERO AO, DE WIT NJ, VAN DER HEIJDEN GJ, RUBIN G, MURIS JW, Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011; 10, CD003460.
85. JOHANNESSON E, SIMREN M, STRID H, BAJOR A, SADIK R, Physical activity improves symptoms in irritable bowel syndrome, a randomized controlled trial. Am J Gastroenterol 2011; 106, 915-22.
86. FORD AC, BRANDT LJ, YOUNG C, CHEY WD, FOXX-ORENSTEIN AE, MOAYYEDI P, Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome, systematic review and meta-analysis. Am J Gastroenterol 2009; 104, 1831-43.
87. ZIJDENBOS IL, DE WIT NJ, VAN DER HEIJDENGJ, RUBIN G, QUARTERO AO, Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009; 21, CD006442.
88. FORD AC, TALLEY NJ, SCHOENFELD PS, QUIGLEY EMM, MOAYYEDI P, Efficacy of antidepressants and psychological therapies in irritable bowel syndrome, systematic review and meta-analysis. Gut 2009; 58, 367-78.
89. MANHEIMER E, WIELAND LS, CHENG Ket al., Acupuncture for rritable bowel syndrome, systematic review and meta-analysis. Am J Gastroenterol 2012; 107, 835-47.
90. SAITO YA, REY E, ALMAZAR-ELDER AE et al., A randomized, double-blind, placebocontrolled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol 2010; 105, 170-7.
91. CHEY WD, LEMBO AJ, MACDOUGALL JE, LAVINS BJ, SCHNEIER H, JOHNSTON JM, Efficacy and safety of linaclotide administered orally for 26 weeks in patients with IBS-C, results from a randomized, doubleblind, placebo-controlled phase 3 trial. Gastroenterology 2011; 5 (Suppl. 1), S135.
92. MONEY ME, WALKOWIAK J, VIRGILIO C, TALLEY NJ, Pilot study, a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea. Frontline Gastroenterol 2011; 2, 48-56.
93. ODUNSI-SHIYANBADE ST, CAMILLERI M, MCKINZIE S et al., Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol 2010; 8, 159-65.
94. PLESH O, WOLFE F, LANE N., The relationship between fibromyalgia and temporomandibular disorders, prevalence and symptom severity. J Rheumatol 1996; 23, 1948-52.
95. SPERBER AD, ATZMON Y, NEUMANN L et al., Fibromyalgia in the irritable bowel syndrome, studies of prevalence and clinical implications. Am J Gastroenterol 1999; 94, 3541-6.
96. YUNUS MB, Central sensitivity syndromes, a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 2008; 37, 339-52.
97. VIERCK CJ JR, Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia) Pain 2006; 124, 242-63
98. DIATCHENKO L, NACKLEY AG, SLADE GD et al., Catechol-O-methyltransferase gene polymorphisms are associated with multiple painevoking stimuli. Pain 2006; 125, 216-24.
99. ABBI B, NATELSON BH, Is chronic fatigue syndrome the same illness as fibromyalgia, evaluating the 'single syndrome' hypothesis. QJM 2012 Aug 26. [Epub ahead of print].
100. CASSISI G, SARZI-PUTTINI P, CAZZOLA M, Chronic widespread pain and fibromyalgia, could there be some relationships with infections and vaccinations? Clin Exp Rheumatol 2011; 29 (Suppl. 69), S118-26.
101. DI FRANCO M, IANNUCCELLI C, BAZZICHI L et al., Misdiagnosis in fibromyalgia, a multicentre study. Clin Exp Rheumatol 2011; 29 (Suppl. 69), S104-8.
102. CAZZOLA M, ATZENI F, SALAFFI F, STISI S, CASSISI G, SARZI-PUTTINI P, Which kind of exercise is best in fibromyalgia therapeutic programmes? A practical review. Clin Exp Rheumatol 2010; 28 (Suppl. 63), S117-24.
103. DI FRANCO M, IANNUCCELLI C, ATZENI F et al., Pharmacological treatment of fibromyalgia. Clin Exp Rheumatol 2010; 28 (Suppl. 63), S110-6.